Biolase Inc logo

Biolase Inc

$ 2.59 0 (0%) 10:08 PM EST
P/E:
At Loss
P/B:
0.83
Market Cap:
$ 21.39M
Enterprise V:
$ 16.76M
Volume:
15.43K
Avg Vol (2M):
38.80K
Also Trade In:
Volume:
15.43K
Market Cap $:
21.39M
PE Ratio:
At Loss
Avg Vol (2-Month):
38.80K
Enterprise Value $:
16.76M
PB Ratio:
0.83
GF Score:
Year:
Embed
To
10Y: -%
Above Low: +NaN%
Below High: NaN%
Alerts Website SEC Filings Stock Report
Dataset
Financial Download

Business Description

Description
Biolase Inc is a US-based medical device company. It develops, manufactures, markets, and sells laser systems in dentistry and medicine. The company also markets, sells and distributes dental imaging equipment, including cone beam digital x-rays and CAD/CAM intraoral scanners. It offers two categories of laser system products: Waterlase (all-tissue) systems and Diode (soft-tissue) systems which allow dentists, periodontists, endodontists, oral surgeons, and other dental specialists to perform a broad range of minimally invasive dental procedures, including cosmetic, restorative, and complex surgical applications. The majority of the company's revenue comes from the United States.
Name Current Vs Industry Vs History
Cash-To-Debt 1.31
Equity-to-Asset 0.43
Debt-to-Equity 0.69
Debt-to-EBITDA -0.91
Piotroski F-Score 4/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -6.72
Distress
Grey
Safe
Beneish M-Score -1.89
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC
Name Current Vs Industry Vs History
5-Day RSI 16.85
9-Day RSI 19.49
14-Day RSI 24.02
6-1 Month Momentum % -57.56
12-1 Month Momentum % -77.74

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 3.17
Quick Ratio 1.99
Cash Ratio 1.4
Days Inventory 209.33
Days Sales Outstanding 37.79
Days Payable 59.09

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -93.9

Financials (Next Earnings Date:2022-11-10 Est.)

BIOL's 30-Y Financials

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with NAS:BIOL

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
To

Annualized Return %

Symbol 1 Week 1 Month 3 Months 6 Months YTD 1 Year 3 Years 5 Years 10 Years

Total Annual Return %

Symbol 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013

Executives

Embed

Valuation Box

Year:
Embed

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $) 44.34
EPS (TTM) ($) -2.97
Beta 0.86
Volatility % 47.39
14-Day RSI 24.02
14-Day ATR ($) 0.260182
20-Day SMA ($) 3.2475
12-1 Month Momentum % -77.74
52-Week Range ($) 2.5401 - 17
Shares Outstanding (Mil) 8.26

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 4
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Biolase Inc Filings

Document Form Filing Date
No Filing Data

Biolase Inc Analysis

Share your research

Headlines

See More
No news.